ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

31.52
Delayed Data
As of 4:00pm ET
 +1.28 / +4.23%
Today’s Change
25.06
Today|||52-Week Range
41.20
+4.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-37.9M-92.5M-164.4M-271.4M
 
 
 
 
 
Depreciation79.0K206.0K647.0K1.8M
 
 
 
 
 
Total Other Cash Flow7.2M16.5M37.9M54.8M
 
 
 
 
 
Funds From Operations-30.6M-75.7M-125.9M-214.8M
 
 
 
 
 
Funds From/For Other Operating Expenses1.1M-9.3M-4.5M-6.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-31.8M-66.4M-121.4M-208.4M
 
 
 
 
 
 
InvestingIncrease In Investments-211.6M-335.4M-269.9M-683.4M
 
 
 
 
 
Decrease In Investments86.1M248.3M419.2M430.9M
 
 
 
 
 
Capital Expenditures-618.0K-180.0K-2.1M-1.5M
 
 
 
 
 
Fixed Asset Disposal12.0K0.000.00--
 
 
Net Cash Flow Investing-126.1M-87.3M147.2M-261.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale111.7M203.9M14.5M518.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.00247.0K14.9M
 
 
 
Other Uses - Financing0.000.00292.0K0.00
 
 
Net Cash Flow - Financing111.7M203.9M14.5M533.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.0K3.0K7.0K2.0K
 
 
 
 
 
 
Net Change In Cash-46.2M50.1M40.3M63.5M